NMNAT3 Protein

📖 Wiki Page

protein1206 wordssynced 2026-04-02

NMNAT3 Protein

<div class="infobox infobox-protein">
<div class="infobox-header">NMNAT3 Protein</div>
<div class="infobox-row"><span class="infobox-label">Protein Name</span><span class="infobox-value">Nicotinamide Mononucleotide Adenylyltransferase 3</span></div>
<div class="infobox-row"><span class="infobox-label">Gene</span><span class="infobox-value">[NMNAT3](/genes/nmnat3)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[Q96T66](https://www.uniprot.org/uniprot/Q96T66)</span></div>
<div class="infobox-row"><span class="infobox-label">Molecular Weight</span><span class="infobox-value">~28.7 kDa (252 aa)</span></div>
<div class="infobox-row"><span class="infobox-label">Subcellular Localization</span><span class="infobox-value">Mitochondria, Cytoplasm</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Family</span><span class="infobox-value">NMN adenylyltransferase family</span></div>
<div class="infobox-row"><span class="infobox-label">Associated Diseases</span><span class="infobox-value">Hereditary hemolytic anemia, mitochondrial dysfunction in neurodegeneration</span></div>
</div>

Overview

...

NMNAT3 Protein

Overview

NMNAT3 (Nicotinamide Mononucleotide Adenylyltransferase 3) is the mitochondrial isoform of the NMNAT enzyme family, catalyzing the synthesis of NAD+ from nicotinamide mononucleotide (NMN) and ATP within the mitochondrial matrix. NAD+ is indispensable for mitochondrial oxidative phosphorylation, the tricarboxylic acid (TCA) cycle, and mitochondrial sirtuin-mediated protein deacetylation. NMNAT3 is encoded by the [NMNAT3](/genes/nmnat3) gene on chromosome 3q23, and although its precise contribution to the mitochondrial NAD+ pool has been debated — with some studies suggesting that NAD+ may also be imported from the cytoplasm — NMNAT3 remains the only characterized NAD+ synthase with confirmed mitochondrial localization.[@berger2005] Loss-of-function mutations in NMNAT3 cause a form of hereditary hemolytic anemia linked to erythrocyte NAD+ depletion, while overexpression studies in neuronal models demonstrate cytoprotective effects against oxidative stress and excitotoxicity.[@falk2014]

Structure and Biochemistry

NMNAT3 is a 252-amino-acid protein that contains an N-terminal mitochondrial targeting sequence (MTS, residues 1–25) cleaved upon import into the mitochondrial matrix. The mature enzyme (~25 kDa) adopts a Rossmann-fold catalytic domain homologous to [NMNAT1](/proteins/nmnat1-protein) and [NMNAT2](/proteins/nmnat2-protein), with conserved residues at the NMN-binding and ATP-binding sites.[@zhou2002] Unlike NMNAT1, which forms a stable hexamer, NMNAT3 crystallizes as a tetramer with a distinct oligomerization interface.[@berger2005]

The catalytic mechanism follows the same two-step adenylyl transfer reaction as other NMNAT isoforms:

ATP binds to the active site and donates its adenylyl moiety to a conserved histidine residue

The AMP group is then transferred to NMN, yielding NAD+ and pyrophosphate (PPi)

NMNAT3 shows lower catalytic efficiency (kcat/Km) for NMN compared to NMNAT1, which may reflect adaptation to the lower NMN concentrations present in the mitochondrial matrix.[@berger2005]

Normal Function in the Nervous System

Mitochondrial NAD+ Homeostasis

Mitochondrial NAD+ is consumed by multiple enzymes essential for neuronal energy metabolism:

Complex I (NADH dehydrogenase) — the entry point of electrons into the respiratory chain; NAD+ accepts electrons from TCA cycle substrates to form NADH, which donates them to Complex I for ATP generation
[SIRT3](/proteins/sirt3-protein) — the major mitochondrial sirtuin, which deacetylates and activates key metabolic enzymes including isocitrate dehydrogenase 2 (IDH2), superoxide dismutase 2 ([SOD2](/proteins/sod2-protein)), and long-chain acyl-CoA dehydrogenase; SIRT3 activity is directly NAD+-dependent[@hirschey2010]
SIRT4 and SIRT5 — additional mitochondrial sirtuins with lipoamidase and desuccinylase/demalonylase activities, respectively

[Neurons](/entities/neurons) are uniquely vulnerable to mitochondrial NAD+ depletion because they rely almost exclusively on oxidative phosphorylation for ATP production, in contrast to [astrocytes](/entities/astrocytes) which can sustain ATP levels through glycolysis.[@lautrup2019]

Mitochondrial Bioenergetics and Quality Control

NMNAT3-dependent NAD+ supports the activity of mitochondrial dehydrogenases in the TCA cycle (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, isocitrate dehydrogenase), which generate NADH for the electron transport chain. In neurons, mitochondria at synaptic terminals have particularly high energy demands to power synaptic vesicle cycling, calcium buffering, and local protein synthesis.[@lautrup2019]

Additionally, mitochondrial NAD+ levels influence the balance between mitochondrial fission and fusion. NAD+ depletion promotes [DRP1](/proteins/dnm1l-protein)-dependent mitochondrial fragmentation and activates the mitophagy pathway through PINK1/Parkin, while adequate NAD+ supports a fused, metabolically efficient mitochondrial network.[@fang2016]

Erythrocyte NAD+ Maintenance

Outside the nervous system, NMNAT3 has a critical role in erythrocytes, which lack nuclei and therefore cannot express NMNAT1. Red blood cell NAD+ is maintained primarily by NMNAT3, and biallelic loss-of-function mutations cause hereditary hemolytic anemia with shortened erythrocyte lifespan.[@falk2014]

Role in Neurodegenerative Disease

Parkinson's Disease

Mitochondrial dysfunction is a hallmark of [Parkinson's disease](/diseases/parkinsons-disease), with multiple PD-associated genes ([PINK1](/genes/pink1), [PRKN/Parkin](/genes/prkn), [DJ-1](/genes/park7)) encoding proteins that function in mitochondrial quality control. NMNAT3 overexpression in dopaminergic neuron cultures protects against:

MPTP/MPP+ toxicity — the classic mitochondrial Complex I inhibitor model of parkinsonism; NMNAT3 overexpression maintains mitochondrial NAD+ and prevents bioenergetic collapse[@felici2015]
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation — alpha-synuclein oligomers bind to TOM20 on the outer mitochondrial membrane, impairing mitochondrial protein import; adequate NAD+ levels through NMNAT3 activity help maintain mitochondrial proteostasis
Rotenone-induced oxidative stress — NMNAT3-derived NAD+ supports SIRT3-mediated deacetylation and activation of SOD2, the primary mitochondrial superoxide scavenger[@hirschey2010]

Alzheimer's Disease

Mitochondrial NAD+ depletion has been documented in [Alzheimer's disease](/diseases/alzheimers-disease) brain tissue and AD mouse models. [Amyloid-beta](/proteins/amyloid-beta) peptides accumulate within mitochondria, inhibiting Complex IV (cytochrome c oxidase) and alpha-ketoglutarate dehydrogenase, compounding the bioenergetic deficit.[@reddy2008] NMNAT3-dependent mitochondrial NAD+ may be a limiting factor for the compensatory upregulation of SIRT3, which has been shown to reduce amyloid-beta-induced mitochondrial dysfunction in hippocampal neuron cultures.

ALS and Motor Neuron Disease

Motor neurons have exceptionally long axons with high mitochondrial content. Mitochondrial NAD+ depletion accelerates the retrograde dying-back axonopathy observed in ALS models. In SOD1-G93A transgenic mice, mitochondrial Complex I activity declines early in disease, and strategies to boost mitochondrial NAD+ (including NMNAT3 overexpression) extend motor function and delay denervation at the neuromuscular junction.[@magrane2014]

NAD+ Decline in Aging

Brain mitochondrial NAD+ levels decline approximately 30–50% with aging in rodent models, driven by increased CD38 NADase activity, reduced NAD+ biosynthetic enzyme expression, and cumulative oxidative damage to mitochondrial NAD+-dependent enzymes.[@gomes2013] This age-related decline creates a permissive background for neurodegenerative disease onset.

Therapeutic Implications

NAD+ Precursor Therapy

NMN and nicotinamide riboside (NR) supplementation increase brain NAD+ in preclinical models, with benefits that depend in part on NMNAT3 activity in mitochondria. NMN supplementation in aged mice restores mitochondrial NAD+, improves Complex I activity, and rescues cognitive deficits.[@gomes2013] Multiple clinical trials of NR and NMN are in progress for Alzheimer's disease and Parkinson's disease.

Mitochondria-Targeted NAD+ Augmentation

Strategies to specifically boost mitochondrial NAD+ include mitochondria-targeted NMN analogs and viral overexpression of NMNAT3. These approaches may achieve greater neuroprotection than systemic NAD+ precursor supplementation, which distributes across all subcellular compartments.[@felici2015]

SIRT3 Activation

Because NMNAT3-generated NAD+ is the rate-limiting co-substrate for [SIRT3](/proteins/sirt3-protein), combined strategies of NAD+ repletion plus SIRT3 activator compounds may synergistically improve mitochondrial function in neurodegeneration.[@hirschey2010]

External Links

[UniProt: Q96T66](https://www.uniprot.org/uniprot/Q96T66)
[PDB: 1NUR](https://www.rcsb.org/structure/1NUR)
[GeneCards: NMNAT3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMNAT3)
[OMIM: 608700](https://www.omim.org/entry/608700)

References

[Berger et al., Subcellular compartmentation and differential catalytic properties of the three human NMN adenylyltransferase isoforms (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/16118205/)

[Falk et al., NMNAT3 mutations cause hemolytic anemia through NAD metabolic deficiency (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25533959/)

[Zhou et al., Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/14982929/)

[Hirschey et al., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20167603/)

[Lautrup et al., NAD+ in brain aging and neurodegenerative disorders (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/28283700/)

[Fang et al., NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/24043828/)

[Felici et al., Pharmacological NAD-boosting approaches to restore mitochondrial function in neurodegeneration (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/24875907/)

[Unknown, Reddy & Beal, Amyloid beta, mitochondrial dysfunction and synaptic damage in Alzheimer's disease (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/16399206/)

[Magrane et al., Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/23417064/)

[Gomes et al., Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/27432255/)

📖 View canonical wiki page →

NMNAT3 Protein

NMNAT3 Protein

Overview

NMNAT3 Protein

Overview

Structure and Biochemistry

Normal Function in the Nervous System

Mitochondrial NAD+ Homeostasis

Mitochondrial Bioenergetics and Quality Control

Erythrocyte NAD+ Maintenance

Role in Neurodegenerative Disease

Parkinson's Disease

Alzheimer's Disease

ALS and Motor Neuron Disease

NAD+ Decline in Aging

Therapeutic Implications

NAD+ Precursor Therapy

Mitochondria-Targeted NAD+ Augmentation

SIRT3 Activation

See Also

External Links

References